Charles Schwab Investment Management Inc Rocket Pharmaceuticals, Inc. Transaction History
Charles Schwab Investment Management Inc
- $521 Billion
- Q1 2025
A detailed history of Charles Schwab Investment Management Inc transactions in Rocket Pharmaceuticals, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 675,481 shares of RCKT stock, worth $4.24 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
675,481
Previous 656,090
2.96%
Holding current value
$4.24 Million
Previous $8.25 Million
45.37%
% of portfolio
0.0%
Previous 0.0%
Shares
28 transactions
Others Institutions Holding RCKT
# of Institutions
258Shares Held
108MCall Options Held
555KPut Options Held
177K-
Rtw Investments, LP New York, NY17.7MShares$111 Million1.93% of portfolio
-
Wellington Management Group LLP Boston, MA12.6MShares$79.2 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.62MShares$41.5 Million0.0% of portfolio
-
Black Rock Inc. New York, NY6.19MShares$38.8 Million0.0% of portfolio
-
Lee Ainslie Maverick Capital LTD | Dallas, Tx5.2MShares$32.6 Million0.68% of portfolio
About ROCKET PHARMACEUTICALS, INC.
- Ticker RCKT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 75,683,696
- Market Cap $475M
- Description
- Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...